Aimo Kannt
R&d
Frankfurt Am Main, HE 65926, Germany
Frankfurt Am Main, HE 65926, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Click chemistry enables rapid development of potent sEH PROTACs using a direct-to-biology approach.
Journal: Chemical communications (Cambridge, England)
Published: October 21, 2025
Glycan-based biological degraders targeting the cytokine immune axis.
Journal: Communications biology
Published: August 12, 2025
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase.
Journal: Journal of medicinal chemistry
Published: June 18, 2025
Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening.
Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening.
Journal: ACS pharmacology & translational science
Published: March 16, 2025
Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2.
Journal: Journal of medical virology
Published: November 16, 2024
Policy makers must adopt agile signal detection tools to strengthen epidemiological surveillance and improve pandemic preparedness.
Journal: Health policy (Amsterdam, Netherlands)
Published: November 08, 2024
Wastewater as an early indicator for short-term forecasting COVID-19 hospitalization in Germany.
Journal: BMC public health
Published: September 21, 2024
Neutralizing IL-38 activates γδ T cell-dependent antitumor immunity and sensitizes for chemotherapy.
Neutralizing IL-38 activates γδ T cell-dependent antitumor immunity and sensitizes for chemotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 12, 2024
Last Updated: 09/26/2026